Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Philippines Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20112
20131
20141
20152
20161
20171
20181
20223
20233
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated6
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anthera Pharmaceuticals2
EMD Serono2
EMD Serono Research & Development Institute, Inc.2
Ablynx, a Sanofi company1
Alumis Inc1
AstraZeneca1
Biogen1
Kezar Life Sciences, Inc.1
MedImmune LLC1
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic17
Autoimmune Diseases3
Lupus Erythematosus, Cutaneous3
Connective Tissue Diseases2
Lupus Erythematosus, Discoid2
Lupus Nephritis2
Immune System Diseases1
Mycobacterium Infections, Nontuberculous1
Proteinuria1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.